Podcasts about ethnic disparities

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Racial and Ethnic Disparities in Catheter Ablation Utilization for Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Host Davide Soldato and guest Dr. John K. Lin discuss the JCO article "Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-For-Service Beneficiaries with Metastatic Breast, Colorectal, Lung, and Prostate Cancer." TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Davide Soldato: Hello, and welcome to JCO After Hours, the podcast where we sit down with authors of the latest articles published in the Journal of Clinical Oncology. I'm your host, Dr. Davide Soldato, a medical oncologist at Ospedale San Martino in Genoa, Italy. Today, we are joined by Dr. Lin, assistant professor in the Department of Health Services Research at the University of Texas MD Anderson Cancer Center. Dr. Lin and I will be discussing the article titled, "Racial and Ethnic Disparities Along the Treatment Cascade Among  Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancer." Thank you for speaking with us, Dr. Lin. Dr. Lin: Thank you so much for having me. I appreciate it. Dr. Davide Soldato: So, just to start, to frame a little bit the study, I just wanted to ask you what prompted you and your team to look specifically at this question - so, racial and ethnic disparities within this specific population? And related to this question, I just wanted to ask how this work is different or builds on previous work that has been done on this research topic. Dr. Lin: Yeah, absolutely. Part of the impetus for this study was the observation that despite people who are black or Hispanic having equivalent health insurance status - they all have  Medicare Fee-for-Service - we've known that treatment and survival differences and disparities have persisted over time for patients with metastatic breast, colorectal, lung, and prostate cancer. And so, the question that we had was, "Why is this happening, and what can we do about it?" One of the reasons why eliminating racial and ethnic disparities in survival among Medicare beneficiaries with metastatic cancer has been elusive is because these disparities are occurring along a lot of dimensions. Whether or not it's because the patient presented late and has very extensive metastatic cancer; whether or not the patient has had a difficult time even seeing an oncologist; whether or not the patient has had a difficult time starting on any systemic therapy; or maybe it's because the patient has had a difficult time getting guideline-concordant systemic therapy because, more recently, these treatments have become so expensive. Disparities, we know, are occurring along all of these different facets and areas of the treatment cascade. Understanding which one of these is the most important is the key to helping us alleviate these disparities. And so, one of our goals was to evaluate disparities along the entire treatment cascade to try to identify which disparities are most important. Dr. Davide Soldato: Thank you very much. That was very clear. So, basically, one of the most important parts of the research that you have performed is really focusing on the entire treatment cascade. So, basically, starting from the moment of diagnosis up to the moment where there was the first line of treatment, if this line of treatment was given to the patient. So, I was wondering a little bit, because for this type of analysis, you used the SEER-Medicare linked database. So, can you tell us a little bit which was the period of time that you selected for the analysis? Why do you think that that was the most appropriate time to look at this specific question? And whether you feel like there is any potential limitation in using this type of database and how you handled this type of limitations? Dr. Lin: Yeah, absolutely. It's a great question. And I want to back up a little bit because I want to talk about the entire treatment cascade because I think that this is really important for our research and for future research. We weren't the first people to look at along the treatment cascade for a disease. Actually, this idea of looking along the treatment cascade was pioneered by HIV researchers and has been used for over a decade by people who study HIV. And there are a lot of parallels between HIV and cancer. One of them is that with HIV, there are so many areas along that entire treatment cascade that have to go right for somebody's treatment to go well. Patients have to be diagnosed early, they have to be given the right type of antiretrovirals, they have to be adherent to those antiretrovirals. And if you have a breakdown in any one of those areas, you're going to have disparities in care for these HIV patients. And so, HIV researchers have known this for a long time, and this has been a big cornerstone in the success of getting people with HIV the treatment that they need. And I think that this has a lot of parallels with cancer as well. And so, I am hoping that this study can serve as a model for future research to look along the entire treatment cascade for cancer because cancer is, similarly, one of these areas that requires multidisciplinary, complex medical care. And understanding where it is breaking down, I think, is crucial to us figuring out how we can reduce disparities. But for your question about the SEER-Medicare linked database, so we looked between 2016 and 2019. That was the most recent data that was available to us. And one of the reasons why we were excited to look at this is because there were some new treatments that were just released and FDA-approved around 2018, which we were able to study. And this included immunotherapy for non–small cell lung cancer, and then it also included androgen receptor pathway inhibitors, the second-generation ones, for prostate cancer. And the reason why this is important is because for some time, as we have developed these new therapies, there's been a lot of concern that there have been disparities in access to these novel therapies because of how expensive they are, particularly for the Medicare population. And so one of the reasons why we looked specifically at this time period was to understand whether or not, in more recent years, these novel therapies, people are having increasing disparities in them and whether or not increasing disparities in these more expensive, newer therapies is contributing to disparities in mortality. That being said, obviously, we're in 2025 and these data are by now six years old, and so there are additional therapies that are now available that weren't available in the past. But I think that, that being said, at least it's sort of a starting point for some of the more important therapies that have been introduced, at least for non–small cell lung cancer and prostate cancer. And the database, SEER-Medicare, is helpful because it uses the population cancer registry, which is the SEER registry cancer registry, linked to Medicare claims. So, any type of medical care that's billed through Medicare, which is going to basically be all of the medical care that these patients receive, for the most part, we're going to be able to see it. And so, I think that this is a really powerful database which has been used in a lot of research to understand what kind of care is being received that has been billed through Medicare. So, one of the limitations with this database is if there is care that's received that was not billed through Medicare, we're not going to be able to see that. And this does not happen probably that frequently, particularly because most patients who have insurance are going to be receiving care through insurance. However, we may see it for some of the oral Part D drugs. Some of those drugs are so expensive that patients cannot pay for the coinsurance during that time. And it's possible that some of those drugs patients were getting for free through the manufacturer. We potentially missed some of that. Dr. Davide Soldato: So, going a little bit into the results, I think that these are very, very interesting. And probably the most striking one is that when we look at the receipt of any type of treatment for metastatic breast, colorectal, prostate, and lung cancer - and specifically when we look at guideline-directed first-line treatments - you observed striking differences. So, I just wanted you to guide us a little bit through the results and tell us a little bit which of the numbers surprised you the most. Dr. Lin: So, what we were expecting is to see large disparities in receiving what we called guideline-directed systemic therapy. And guideline-directed systemic therapy during this time kind of depended on the cancer. So, we thought that we were going to see large disparities in guideline-directed therapy because these were the more novel therapies that were approved, and thus they were going to be the more expensive therapies. And so, what this meant was for colorectal cancer, this was going to be any 5-FU–based therapy. For lung cancer, this was going to be any checkpoint inhibitor–based therapy. For prostate cancer, this was going to be any ARPI, so this was going to be things like abiraterone or enzalutamide. And for breast cancer, this was going to be CDK4 and 6 TKIs plus any aromatase inhibitor. And so, for instance, for breast, prostate, and lung cancer, these were going to be including more expensive therapies. And so, what we expected to see was large disparities in receiving some of these more expensive, novel therapies. And we thought we were going to see fewer disparities in receiving some of the cheaper therapies, such as aromatase inhibitors, 5-FU, older platinum chemotherapies for lung cancer, and ADT for prostate cancer. We were shocked to find that we saw large racial and ethnic disparities in seeing some of the older, cheaper chemotherapies and hormonal therapies. So for instance, for breast cancer, 59% of black patients received systemic therapy, whereas 68% of white patients received systemic therapy. For colorectal, only 23% of black patients received any systemic therapy versus 34% of white patients. For lung, only 26% of black patients received any therapy, whereas 39% of white patients did. And for prostate, only 56% of black patients received any systemic therapy versus 77% of white patients. And so, we were pretty shocked by how large the disparities were in receiving these cheap, easy-to-access systemic therapies. Dr. Davide Soldato: Thank you very much. So, I just wanted to go a little bit deeper in the results because, as you said, there were striking differences even when we looked at very old and also cheap treatments that, for the majority of the patients that were included inside of your study, were actually basically available for a very small price to these patients who had the eligibility for Medicare or Medicaid. And I think that one of the very interesting parts of the research was actually the attention that you had at looking how much of these disparities could be explained by several factors. And actually, one of the most interesting results is that you observed that low-income subsidy status was actually a big determinant of these disparities in terms of treatment. So, I just wanted to guide us a little bit through these results and then just your opinion about how these results should be interpreted by policymakers. Dr. Lin: Yeah, absolutely. I'm going to explain a little bit about what low-income subsidy status is and dual-eligibility status. Some of the listeners may not know what low-income subsidy status or dual-eligibility status is. Low-income subsidy status is part of Medicare Part D. Medicare Part D is an insurance benefit that allows patients to receive oral drugs. So these are drugs that are dispensed through the pharmacy, such as the CDK4/6 inhibitors, as well as second-generation ARPIs in our study. For patients who have Medicare Part D and whose income is low enough - falls below a certain federal poverty level threshold - those patients will receive their oral drugs for much cheaper. And this is really important for some of these more novel therapies because for some of these more novel therapies, if you don't have low-income subsidy status, you may be paying thousands of dollars for a single prescription of those drugs. Whereas if you have low-income subsidy status, you may be paying less than $10. And so that difference, greater than $1,000 or $2,000 versus less than $10, one would think that the patient who's paying less than $10 would be much more likely to receive those therapies. So that's low-income subsidy status. Low-income subsidy status, importantly, doesn't apply for infused medications like immunotherapy. But it's important to know that most people with low-income subsidy status - about 88% - are also dual-eligible. What dual-eligible means is that they have both Medicare and Medicaid. Medicare being the insurance that everybody has in our study who's greater than 65. And Medicaid is the state-run but federally subsidized insurance that patients with low incomes have. And so patients who are dual-eligible - and about 87% of those with low-income subsidy status are dual-eligible - those patients have both Medicaid and Medicare, and they basically pay next to nothing for any of their medical care. And that's because Medicare will reimburse most of the medical care and the copays or coinsurance are going to be covered by Medicaid. So Medicaid is going to pick up the rest of the bill. So, most of the patients who have low-income subsidy status who are dual-eligible, these patients pay almost nothing for their medical care - Part B or Part D, any of their drugs. And so, one would expect that if cost were the main determinant of disparities in cancer care, then one would expect that dual-eligibles, most of them would be receiving treatment because they're facing minimal to no costs. What we found is that when we broke down the racial and ethnic disparity by a number of factors - including LIS status/dual eligibility, age, the number of comorbidities, etcetera - what we found was that the LIS or dual-eligibility status explained about 20% to 45% of the disparities that we saw in receiving treatment. And what that means is despite these patients paying next to nothing for their drugs, these are the most likely patients to not be treated for their cancer at all. So they're most likely to basically be diagnosed, survive for two months, see an oncologist, and then never receive any systemic therapy for their cancer. And this is not just chemotherapies for colorectal or lung cancer. This includes cheaper, easier-to-tolerate hormonal therapies that you can just take at home for breast cancer, or you can get every six months for prostate cancer, that people who even have poorer functional status are able to take. However, for whatever reason, these dual-eligible or LIS patients are very unlikely to receive treatment compared to any other patient. The low likelihood of treating this group of patients, that explains a large portion of the racial and ethnic disparities that we see. Dr. Davide Soldato: And one thing that I think is very interesting and might be of potential interest to our listeners is, did you compare survival outcomes in these different settings? And did you observe any significant differences in terms of racial and ethnic disparities once you saw that there was a significant difference when looking at both receipt of any type of treatment and also guideline-directed treatments? Dr. Lin: We saw that there were large disparities in survival by race and ethnicity when you look overall. However, when you just account for the patients who received any systemic therapy at all - not just guideline-directed systemic therapy - those differences in survival essentially disappeared. And so, what that suggests is that if black patients were just as likely to receive any systemic therapy at all as white patients, we would expect that the survival differences that we were seeing would disappear. And this is not even just looking at guideline-directed systemic therapy. This was looking just at systemic therapy alone. And so, while guideline-directed systemic therapy should be a goal, our research suggests that if we are to close the gap in disparities in overall survival among black and white patients, we must first focus on patients just receiving any type of treatment at all. And that should be the very first focus that policymakers, that leaders in ASCO, that health system leaders, that physicians, that we should focus on: just trying to get any type of treatment to our patients who are poorer or black. Dr. Davide Soldato: Thank you very much. And this was not directly related to the research that you performed, but going back to this very point - so, increasing the number of patients that receive any kind of systemic treatment before looking at guideline-directed treatments - what would you feel would be the best way to approach this in order to decrease the disparities? Would you look at interventions such as financial navigation or maybe improving referral pathways or providing maybe more culturally adapted information to the patients? Because in the end, what we see is disparities based on racial and ethnicity. We see that we can reduce these disparities if we get these patients to the treatment. But in the end, what would you feel is the best way to bring patients to these types of treatments? Dr. Lin: I think the most important thing is to understand that these disparities are not primarily happening because of the high cost of cancer treatment. These disparities are happening because of other social vulnerabilities that these patients are facing. And so these vulnerabilities could be a lot of things. It could be mistrust of the medical system. It could be fear of chemotherapy or other treatments. It could be difficulty taking time off of work. It could be any number of things. What we do know is when we've looked at the types of interventions that can help patients receive treatment, navigation is probably the most effective one. And the reason why I think that is because when patients don't receive treatment because of social vulnerability, I sort of look at social vulnerability like links in a chain. Any weakest link is going to result in the patient not receiving treatment. This may be because they have a hard time taking time off of work. This may be because they had a hard time getting transportation to their physician. It may be because they had an interaction with a physician, but that interaction was challenging for the patient. Maybe they mistrusted the physician. Maybe they're worried about the medical system. If any of these things goes wrong, the patient is not going to be treated. The patient navigator is the only person who can spot any of those weak links within the chain and address them. And so, I think that the first thing to do is to get patient navigation systems in place for our vulnerable patients throughout the United States. And this is incredibly important because in Medicare, patient navigation is reimbursable. And so this is not something that's ‘pie in the sky'. This is something that's achievable today. The second thing is that it's really important that we see these vulnerabilities happening for patients who are dual-eligible, who have both Medicare and Medicaid. One of the reasons why this is important is because there has been a lot of research outside of what we've done that has shown vulnerabilities for dual-eligible patients who have Medicare for a number of different diseases. And the reason why is because, although patients are supposed to have the benefits of both Medicare and Medicaid, usually these two insurances do not play nicely together. It creates a huge, bureaucratic, complex mess and maze that most of these patients are unable to navigate. And so many of these patients are unable to actually receive the full reimbursement from both Medicare and Medicaid that they should be getting because those two insurers are not communicating well. And so the second thing is that national cancer organizations need to be supporting policies and legislation that is already being discussed in Congress to revamp the dual-eligible system so that it facilitates these patients getting properly reimbursed for their care from both Medicare and Medicaid and these systems working together well. The third thing is that Medicaid itself has many benefits that can allow patients to receive care, like they have transportation benefits so that patients can get to and from their doctor's appointments with ease. And so I think this will be additionally very, very helpful for patients. The last thing is, you know, it's possible that future innovations such as telemedicine and tele-oncology and cancer care at home can also make it easier for some of these patients who may be working a lot to receive care. But what I would say is that our study should be a call for healthcare delivery researchers to start piloting interventions to be able to help these patients receive systemic therapy. And so what this could look like is trying to get that care navigation and implement that in clinics so that patients can be receiving the care that they need. Dr. Davide Soldato: Thank you very much. That was a very clear perspective on how we can tackle this issue. So, I just wanted to close with a sort of personal question. I was wondering what led you to work specifically in this research field that is very challenging, but I think it's particularly critical in healthcare systems like in the United States. Dr. Lin: Yeah, absolutely. One of the most important things for me as an oncologist and a researcher is being able to know that all patients in the United States - and obviously abroad - who have cancer should be able to receive the kind of care that they deserve. I don't think that patients, because their incomes are lower or because their skin looks a certain color or because they live in rural areas, these shouldn't be determinants of whether or not cancer patients are receiving the care that they need. We can develop and pioneer the very best treatments and breakthroughs in oncology, but if our patients are not receiving them - if only 20% of our patients with colon cancer or lung cancer are receiving any type of systemic therapy, who are black - this is a big problem. But this is something that I think that our system can tackle. We need to get these breakthroughs that we have in oncology to every single cancer patient in America and every single cancer patient in the world. I think this is a goal that all oncologists should have, and I think that this is something that, honestly, is achievable. I think that research is a powerful tool to give us a lens into understanding exactly why it is that certain patients are not getting the care that they deserve. And my goal is to continue to use research to shed light on why our system is not performing the way that we all want it to be. Dr. Davide Soldato: Circling back to your research, actually the manuscript that was published was supported by a Young Investigator Award by the American Society of Clinical Oncology. So, was this the first step of a more broad research, or do you have any further plans to go deeper in this topic? Dr. Lin: Yeah, absolutely. First, I want to thank the ASCO Young Investigator Award for funding this research because I think it's fair to say that this research would not have happened at all without the support of the ASCO YIA. And the fact that ASCO is doing as much as it can to support the future generation of cancer researchers is incredible. And it's a huge resource, and having it come at the time that it did is critical for so many of us. So I think that this is an unbelievable thing that ASCO does and continues to do with all of its partners. For me, yeah, this is definitely a stepping stone to further research.  Medicare Fee-for-Service is only one part of the population. I want to spread this research and extend it to patients who have other types of insurances, look at other types of policies, and also try to conduct some of the cancer care delivery research that's needed to try to pilot some interventions that can resolve this problem. So hopefully this is the first step in a broader series of studies that we can all do collectively to try to eliminate racial and ethnic disparities in cancer care and survival. Dr. Davide Soldato: So, I think that we've come at the end of this podcast. Thank you again, Dr. Lin, for joining us today. Dr. Lin: Thank you so much. It was a pleasure to be a part of this. Dr. Davide Soldato: So, we appreciate you sharing more on your JCO article, "Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancer." If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

Approximately 200 000 people are hospitalized for diverticulitis each year in the US, and the incidence of diverticulitis is increasing, particularly among younger people. Author Anthony Charles, MD, MPH, of the University of Vermont and JAMA Deputy Editor Mary M. McDermott, MD, discuss current evidence regarding the epidemiology, diagnosis, and treatment of diverticulitis. Related Content: Diverticulitis Quality-of-Life and Recurrence Outcomes Following Laparoscopic Elective Sigmoid Resection vs Conservative Treatment Following Diverticulitis Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor–Positive, Node-Negative Breast Cancer ----------------------------------- JAMA Editors' Summary

In this episode, I'm excited to welcome Dr. Meera Shah from Nova IVF in Mountain View, CA. Dr. Shah is a double board-certified OB-GYN and reproductive endocrinology and infertility specialist.    Together, we're diving into a wide range of fertility-related questions. We'll discuss everything from pregnancy chances after embryo transfer and the impact of birth control on fertility to the best IVF protocols, donor eggs, and the role of genetic testing.   We also explore fascinating topics like slow-developing embryos, how caffeine and alcohol affect fertility treatments, and advanced genetic testing for embryos.⁠ Read the full show notes on Dr. Aimee's website Find Dr. Meera Shah at Nova IVF here Do you have questions about IVF? Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, January 13, 2025 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org  where you can schedule a consultation. More ways to connect with Dr. Aimee: Subscribe to my YouTube channel for more fertility tips! Subscribe to the newsletter to get updatesFollow on Instagram

Drs. Jill Mhyre and Paul Potnuru discuss the article “Racial and Ethnic Disparities in Epidural Blood Patch Utilization Among Obstetric Patients in the United States: A Nationwide Analysis, 2016–2020” published in the December 2024 issue of Anesthesia & Analgesia.

Tony Sewell is a British educational consultant, author, and former chair of the Commission on Race and Ethnic Disparities, known for his work on education reform and his controversial report on racial inequality in the UK. In this interview we discuss why Britain's racial and social inequality debates are more about class than race. He unpacks the misconceptions surrounding racism, the flaws in the education system, and how family structure impacts outcomes. In this eye-opening conversation, Tony explains how nuanced, data-driven policies can better address inequality and improve opportunities for all.

In this episode of the Award-winning PRS Journal Club Podcast, 2024 Resident Ambassadors to the PRS Editorial Board – Rami Kantar, Yoshi Toyoda, and Amanda Sergesketter- and special guest, Scott Bartlett, MD, discuss the following articles from the November 2024 issue: “A National Assessment of Racial and Ethnic Disparities in Cleft Lip Repair” by Peck, Parsaei, Jazayeri, et al. Read the article for FREE: https://bit.ly/RacialCleftLipRepair Special guest, Dr. Scott Bartlett, is the former chair of Plastic Surgery at the Children's Hospital of Philadelphia and is the director of the craniofacial program at CHOP where he also holds The Mary Downs Endowed Chair in Pediatric Craniofacial Treatment and Research, in addition to being a Professor of Plastic Surgery at The Perelman School of Medicine at The University of Pennsylvania. He obtained his medical degree at Washington University in St. Louis followed by plastic surgery training at The Massachusetts General Hospital, Harvard Medical School, and pediatric and craniomaxillofacial surgery fellowship at The Children's Hospital of Philadelphia. Dr. Bartlett is an international authority in craniofacial surgery and won the AAPS Clinician of the Year award in 2023. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCNov24Collection

The United States spends more on healthcare than any other high-income country, yet we have some of the worst population health outcomes. Our health care system is designed in such a way that racial and ethnic disparities are inevitable, and the differences are extreme: the life expectancy difference between white women and black men is over a decade. How can we fix the system to ensure health care equity for all?  A new National Academies report called Ending Unequal Treatment: Strategies to Achieve Equitable Health Care and Optimal Health for All tackles this question. Building on a 2003 report on racial and ethnic disparities in healthcare, the new report finds that little progress has been made in closing those equity gaps over the past two decades. On this episode, host Sara Frueh talks to Georges Benjamin, cochair of the report committee and executive director of the American Public Health Association. They discuss how the health care system creates disparities and how we can fix them.  Resources:  Read the National Academies reports on health care inequality: Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (2003), and Ending Unequal Treatment: Strategies to Achieve Equitable Health Care and Optimal Health for All (2024)

Kamal and Camilla are joined for a forceful but intelligent debate by pro-reparations journalist and descendant of slave owners Laura Trevelyan and anti-reparations Conservative peer Lord Tony Sewell, who is the former Chair of the Commission on Race and Ethnic Disparities.It's the Commonwealth heads of government meeting in Samoa, with leaders of the 56 Commonwealth nations all gathering for the first summit since King Charles took to the throne. Some of those attending from African and Caribbean nations have talked of using the occasion to press Keir Starmer into paying financial reparations for Britain's role in the slave trade.Is there any case for atoning for the past monetarily, or would all parties be better off discussing how to work more closely in the future?We want to hear from you! Email us at TheDailyT@telegraph.co.uk or find us on X, Instagram and TikTok @dailytpodcastSenior Producer: John CadiganExecutive Producer: Louisa WellsAdditional production from James ShieldPlanning Editor: Venetia RaineyStudio Operator: Meghan SearleVideo Editor: James EnglandSocial Media Producer: Ji-Min LeeEditor: Camilla TomineyOriginal music by Goss Studio Hosted on Acast. See acast.com/privacy for more information.

On this episode of Managed Care Cast, we're talking with Benjamin Ukert, PhD, of Elevance Health's Public Policy Institute. His study, "Racial and Ethnic Disparities in Prior Authorizations for Patients With Cancer," evaluated prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.

Howie and Harlan discuss health and healthcare issues in the headlines, including a powerful—but dangerous—new gene therapy, racial disparities in excess deaths during the COVID pandemic, and the limited insurance coverage for highly effective new obesity drugs.  Links: The Physician Shortage “Opening the Door Wider to International Medical Graduates—The Significance of a New Tennessee Law” “New Licensure Pathway for Some Internationally Trained Physicians” “Brain-drain and health care delivery in developing countries” “Talk of an Immigrant ‘Invasion' Grows in Republican Ads and Speech” Subspecialty Expertise from AI “Towards Democratization of Subspeciality Medical Expertise” Gene Therapy “7 children developed blood cancer after Bluebird Bio gene therapy for rare neurological disease” National Institute of Neurological Disorders and Stroke: Adrenoleukodystrophy An AI Warning from a Nobel Laureate Nobel Prize: Nobel Prize in Physics “Why the Godfather of A.I. Fears What He's Built” “Unions Give Workers a Voice Over How AI Affects Their Jobs” Conflicts of Interest and the Role of Peer Reviewers “Medical journal peer reviewers are paid millions by industry, study finds” “Does industry funding equal conflict of interest? Often it does, Yale authors claim” COVID, Race, and Excess Deaths “Racial and Ethnic Disparities in Age-Specific All-Cause Mortality During the COVID-19 Pandemic” Insurance Coverage for GLP-1 Drugs KFF: 2024 Employer Health Benefits Survey “The Miracle Weight-Loss Drug Is Also a Major Budgetary Threat” CDC: Adult Obesity Facts Mothers in Medicine “So Visibly a Mother” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

State-level racial and ethnic disparities in buprenorphine treatment duration in the United States  The American Journal on Addictions National trends reveal a concerning escalation in racial and ethnic disparities in buprenorphine treatment duration for opioid use disorder. This study examined such disparities at the state level. Analyzing 9,040,620 buprenorphine prescriptions dispensed between January 2011 and December 2020 from IQVIA Longitudinal Prescription data, the study revealed substantial statewide variations in racial and ethnic disparities. Specifically, 21 states showed longer treatment durations for White people across all episodes, and 8 states displayed similar trends among episodes lasting ≥180 days. Longer treatment durations for White people in both overall and long-term episodes were exhibited in 5 states, and 15 states showed no racial and ethnic disparities.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM  

As summer comes to a close on Planet Normal, in this the third and final of the three part best of the rocket series, our co-pilots take a look back at some of their most explosive voyages on the rocket of right thinking from the year so far.In March, the co-pilots interviewed author and filmmaker Martin Durkin about his latest film Climate The Movie - The Cold Truth. The film takes issue with what he calls ‘climate alarmism' - a trend which, Durkin says, does not reflect scientific reality.And finally, in April, Liam interviewed Tory Peer Dr Tony Sewell. Dr Sewell Chaired the committee which produced the highly-influential 2021 report of the Commission on Race and Ethnic Disparities. He joined the rocket of right thinking for a return mission again to discuss his new book Black Success.Read more from Liam: https://www.telegraph.co.uk/authors/liam-halligan/ |Read more from Allison: https://www.telegraph.co.uk/authors/a/ak-ao/allison-pearson/ |Need help subscribing or reviewing? Learn more about podcasts here: https://www.telegraph.co.uk/radio/podcasts/podcast-can-find-best-ones-listen/ |Email: planetnormal@telegraph.co.uk |For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/normal | Hosted on Acast. See acast.com/privacy for more information.

“Women in the postpartum period need things, right? I think that there's still a major gap, even though we know if you're in maternal health, you know, over and over again that there's not enough that exists for women in the postpartum period—and that's where the majority of pregnancy related deaths happen.” In this episode, Morgan V. Davis, Kaitlyn Hernandez-Spalding, Rasheeta Chandler, and Natalie Hernandez-Green discuss their recent scoping review which examined the perceptions and use of mHealth in postpartum Black Women. They share their methodology, key findings, and recommendations for improving the postpartum outcomes of this population. This episode references the article “Examining the Perceptions of mHealth on Racial and Ethnic Disparities in Postpartum Health for Black Women: A Scoping Review” by Natalie Hernandez-Green and colleagues.

In this episode of the Changing Higher Ed podcast, Drumm McNaughton welcomes back Dr. Zack Mabel, Research Professor and Director of Research, and Kathryn Campbell, Associate Director of Editorial Policy and Senior Editor/Writer, from the Georgetown University Center on Education and the Workforce (CEW). They discuss the findings of CEW's recent report, "The Great Misalignment: Addressing the Mismatch Between the Supply of Certificates and Associates Degrees and the Future Demand for Workers in the U.S. Labor Markets," which highlights the severe disconnect between the credentials higher education institutions are producing and the skills employers need in the workforce. Key Discussion Points The Extent of the Misalignment: Only 50% of colleges use labor market data to guide program development or share the information with prospective students. To align with projected labor market demand through 2031, at least 50% of middle-skill credentials would need to be granted in different fields of study in half of the nation's local labor markets. Importance of Labor Market Alignment for Middle Skills Providers: Misalignment between credentials produced and employer needs varies substantially across regions. Perfect alignment may not be realistic, but the magnitude of the mismatch shows considerable room for improvement. Racial and Ethnic Disparities in Access to Aligned Programs: American Indian and Alaska Native adults are 3 to 18 times more likely to live in a community with no local middle-skill provider. Among those living near middle-skill institutions, Hispanics are the least likely to reside in communities with a strong alignment between credential production and workforce demand. Strengthening Career Counseling and Transfer Pathways: The current counseling system in high schools is understaffed and under-resourced to provide sufficient guidance. Over a quarter of middle-skills students are in liberal arts and sciences programs oriented toward transfer, but fewer than half successfully make that transition within six years. Using Labor Market Data for Program Improvement: Institutions need to utilize labor market data more strategically and systematically. Colleges need sufficient resources and staff expertise to collect, analyze, and translate this information into action. A collaborative regional approach to program development is essential. Three Key Takeaways for University, College, and Community College Presidents and Boards: Explore ways to collaborate with other local education and training providers to optimize the alignment of credentials with labor market demand. Invest heavily in interpersonal connections and support services that help students choose and complete programs leading to high-demand careers. Be vocal about the need for resources and support to effectively utilize labor market data for program improvement.   Read the transcript on our website → https://changinghighered.com/improve-student-employability-the-great-misalignment-report/ #HigherEducation #StudentEmployability #MiddleSkillJobs   About Our Podcast Guests Kathryn Peltier Campbell is Associate Director of Editorial Policy and Senior Editor/Writer at the Georgetown University Center on Education and the Workforce. In her role, she directs content development for CEW's reports and collaborates on editorial strategy. She has extensive experience editing and writing publications focused on topics such as diversity and equity in postsecondary education, higher education's civic mission, and the value of liberal education in contemporary contexts. She has a deep interest in ensuring that every individual has the opportunity and means to contribute to—and thrive in—the workforce, civil society, and life. Kathryn has an MA in English from the University of Virginia, where she additionally earned a BA with a double major in English and physics.   Zack Mabel is a research professor of education and economics at the Georgetown University Center on Education and the Workforce, where he leads research projects that leverage insights from labor and behavioral economics to promote educational opportunity, equity, and economic mobility. His work is motivated by the goal of improving college and later life outcomes for members of historically marginalized groups to achieve a shared vision of economic prosperity in the United States. Prior to joining CEW, he worked most recently as a policy research scientist at the College Board. Zack earned his BA from Brandeis University, MPP from the University of Michigan, and EdD in Quantitative Policy Analysis of Education from the Harvard Graduate School of Education.   About the Host Dr. Drumm McNaughton is a consultant to higher education institutions in governance, accreditation, strategy and change, and mergers. To learn more about his services and other thought leadership pieces, visit his firm's website: https://changinghighered.com/.   The Change Leader's Social Media Links LinkedIn: https://www.linkedin.com/in/drdrumm/ Twitter: @thechangeldr Email: podcast@changinghighered.com  

Jody shares his general approach to managing hypertension in primary care. Links: 2020 IHS Hypertension Guidelines 2023 EHS Hypertension Guideline Update Racial & Ethnic Disparities in Hypertension

Dr. Colin Orr interview Dr. Salam Abdus from AHRQ regarding his recent piece, "Racial and Ethnic Disparities in Attendance to Well-Child Visit Recommendations during COVID-19" which documented widening disparities in well child attendance by race and ethnicity in during the pandemic. Full article online here: https://www.academicpedsjnl.net/article/S1876-2859(24)00146-3/abstract  

Between 2019 and 2021, pediatric mortality rates had the largest increases in at least half a century. Steven H. Woolf, MD, MPH, of Virginia Commonwealth University Center on Society and Health, joins JAMA Associate Editor Tracy A. Lieu, MD, MPH, to discuss how racial and ethnic disparities and specific causes have factored into these increases and what this means for policymakers and clinicians. Related Content: Racial and Ethnic Disparities in All-Cause and Cause-Specific Mortality Among US Youth Injury Prevention Science and Firearm Injury in Pediatric Health

We use Monetary Metals to buy gold and earn interest on it! Find out more https://monetary-metals.com/triggernometry/ Mercy Muroki is a social policy researcher, commentator and columnist. She was a member of the UK government's Commission on Race and Ethnic Disparities. In 2023 she became a policy adviser for then Minister for Women and Equalities Kemi Badenoch where she worked on issues such as DEI in the workplace, immigration, social cohesion, trans guidance in schools and more. SPONSOR: https://GETSUPERBEETS.COM Use Promo Code: TRIG to get a free 30-day supply + 15% off your first order Join our Premium Membership for early access, extended and ad-free content: https://triggernometry.supercast.com OR Support TRIGGERnometry Here: Bitcoin: bc1qm6vvhduc6s3rvy8u76sllmrfpynfv94qw8p8d5 Music by: Music by: Xentric | info@xentricapc.com | https://www.xentricapc.com/ YouTube: @xentricapc Buy Merch Here: https://www.triggerpod.co.uk/shop/ Advertise on TRIGGERnometry: marketing@triggerpod.co.uk Join the Mailing List: https://www.triggerpod.co.uk/#mailinglist Find TRIGGERnometry on Social Media: https://twitter.com/triggerpod https://www.facebook.com/triggerpod/ https://www.instagram.com/triggerpod/ About TRIGGERnometry: Stand-up comedians Konstantin Kisin (@konstantinkisin) and Francis Foster (@francisjfoster) make sense of politics, economics, free speech, AI, drug policy and WW3 with the help of presidential advisors, renowned economists, award-winning journalists, controversial writers, leading scientists and notorious comedians. Learn more about your ad choices. Visit megaphone.fm/adchoices

SPARK on the Circle, a program that closes parts of Monument Circle for arts and culture events, returns to downtown Indianapolis in June. A new report released Thursday shows racial and ethnic disparities persist in health care access, quality, and outcomes across the nation, including in Indiana. Ivy Tech Community College will offer free classes for Indiana high schoolers this summer. Paige Carter, youth council member for Project Unloaded, talks about the organization's goals around gun violence and its impact in the state. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. Today's episode of WFYI News Now was produced by Abriana Herron, Drew Daudelin and Kendall Antron with support from News Director Sarah Neal-Estes.

Dr. Meera Shah from Nova IVF in Mountain View, California joins me on the podcast today to talk about differences and disparities in reproductive health and IVF outcomes among people of different ethnicities. Dr. Shah has done a great deal of research on this topic and she will be sharing her work. More specifically, we'll be talking about: the timing of a girl's first period, fibroids, menopause, miscarriage, and IVF outcomes based on ethnicity and how this information could help you.⠀ Read the full show notes on Dr. Aimee's website Find Dr. Meera Shah at Nova IVF here Would you like to learn about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, April 22, 2024 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org  where you can schedule a consultation. More ways to connect with Dr. Aimee: Subscribe to my YouTube channel for more fertility tips! Subscribe to the newsletter to get updatesFollow on Instagram

Lead Story: Racial and Ethnic Disparities in Geographic Availability of Buprenorphine Journal of Addiction Medicine To identify whether buprenorphine availability equitably meets the needs of diverse populations, this study examined the differential geographic availability of buprenorphine in areas with greater concentrations of racial and ethnic minority groups. There were 45% to 55% fewer prescribers in urban areas and 62% to 79% fewer prescribers in rural areas as minority composition increased. Differences in dispensed buprenorphine per capita were similar but larger in magnitude. Achieving more equitable buprenorphine access requires not only increasing the number of buprenorphine-prescribing clinicians; in urban areas with higher racial and ethnic minority group populations, it also requires efforts to promote greater buprenorphine prescribing among already prescribing clinicians. Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Commentary by Dr. Valentin Fuster

Interview with Marshall H. Chin, MD, MPH, and Lucila Ohno-Machado, MD, PhD, MBA, authors of Guiding Principles to Address the Impact of Algorithm Bias on Racial and Ethnic Disparities in Health and Health Care. Hosted by JAMA Network Open Associate Editor Angel N. Desai, MD, MPH. Related Content: Guiding Principles to Address the Impact of Algorithm Bias on Racial and Ethnic Disparities in Health and Health Care

Dr. Aaron Samuel Breslow (Montefiore Medical Center and Albert Einstein College of Medicine) joins AJP Audio to discuss the racial and ethnic disparities in the impact of COVID-19 and pandemic related stressors and adverse mental health outcomes on health care workers in the Bronx, New York.  Following we'll once again check in with American Journal of Psychiatry Editor-in-Chief Dr. Ned Kalin on the rest of the December issue of AJP. Breslow interview [00:56] Why look at the Bronx in particular? [2:54] COVID-19 related stressors and pandemic related stressors [05:27] Unrelated adverse mental health outcomes [07:40] Limitations [09:29] Policy considerations [11:39] Further research [14:22] Kalin interview [16:17] Breslow et al. [16:34] Guintivano et al. [18:36] Copeland et al. [22:10] Joseph et al. [25:21] Shim and Rodriguez [27:15] Transcript Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Stitcher, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. How authors may submit their work. Follow the journals of APA Publishing on Twitter. E-mail us at ajp@psych.org

Albert Farias, PhD is an assistant professor in the Department of Population and Public Health Sciences at the Keck School of Medicine of USC. His research is devoted to helping eliminate racial/ethnic disparities in cancer outcomes by furthering the understanding of how the provision of medical care contributes to racial/ethnic disparities in cancer incidence and outcomes. Farias has applied his academic training with a unique perspective as a first-generation college graduate to explain the existence of racial/ethnic health disparities and identify health inequities in cancer care.Learn more about this episode and others at pphs.usc.edu/podcastStay in the loop - subscribe to the Preventive Dose newsletter for monthly news straight to your inbox.Follow us on social - find us at @uscpphs Instagram TikTok Facebook LinkedIn X YouTube

Commentary by Associate Editor Mary Walsh

Yesterday, Dr. Meera Shah of Nova IVF was a guest on The Egg Whisperer Show podcast and we talked about ethnic differences that exist in women's reproductive health, and how they impact IVF outcomes.⁠ ⁠So many of you wrote in asking about our interview that I wanted to bring Dr. Shah back, and in this episode we answered your fertility questions, live.  Read the full show notes on Dr. Aimee's website Find Dr. Meera Shah at Nova IVF here Do you have questions about IVF? Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, August 21st, 2023 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Looking for the best products to support you while you're TTC? Get Dr. Aimee's brand new Conception Kit here.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org  where you can schedule a consultation. More ways to connect with Dr. Aimee: Subscribe to my YouTube channel for more fertility tips! Subscribe to the newsletter to get updatesFollow on Instagram

Yesterday, Dr. Meera Shah of Nova IVF was a guest on The Egg Whisperer Show podcast and we talked about ethnic differences that exist in women's reproductive health, and how they impact IVF outcomes.⁠ ⁠So many of you wrote in asking about our interview that I wanted to bring Dr. Shah back, and in this episode we answered your fertility questions, live.  Read the full show notes on Dr. Aimee's website Find Dr. Meera Shah at Nova IVF here Do you have questions about IVF? Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, August 21st, 2023 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Looking for the best products to support you while you're TTC? Get Dr. Aimee's brand new Conception Kit here.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org  where you can schedule a consultation. More ways to connect with Dr. Aimee: Subscribe to my YouTube channel for more fertility tips! Subscribe to the newsletter to get updatesFollow on Instagram

Dr. Meera Shah from Nova IVF in Mountain View, California joins me on the podcast today to talk about differences and disparities in reproductive health and IVF outcomes among people of different ethnicities. Dr. Shah has done a great deal of research on this topic and she will be sharing her work. More specifically, we'll be talking about: the timing of a girl's first period, fibroids, menopause, miscarriage, and IVF outcomes based on ethnicity and how this information could help you.⠀ Read the full show notes on Dr. Aimee's website Find Dr. Meera Shah at Nova IVF here Would you like to learn about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, August 21st, 2023 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom. Looking for the best products to support you while you're TTC? Get Dr. Aimee's brand new Conception Kit here.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org  where you can schedule a consultation. More ways to connect with Dr. Aimee: Subscribe to my YouTube channel for more fertility tips! Subscribe to the newsletter to get updatesFollow on Instagram

In the 46th episode of the #RehabCast, our host Dr. Bill Niehaus first meets with Occupational Therapist Stephanie Kubiak, PhD and Associate Professor Elliot Sklar, PhD to discuss Racial and Ethnic Disparities of Social Participation After Tetraplegia (https://www.archives-pmr.org/article/S0003-9993(23)00109-0/fulltext). Dr Niehaus then welcomes Psychologists Dr Jane Duff and Lucy Grant to look into when clinicians should help with the anxiety response following a spinal cord injury (https://www.archives-pmr.org/article/S0003-9993(23)00219-8/fulltext ). #RehabCast is the PM&R podcast for all of rehabilitation medicine: physiatry, occupational therapy, physical therapy, speech language pathology, neuropsychology, rehabilitation nursing, and more. #RehabCast #ACRM #SpinalCordInjury #SCI #SCIrehab #rehabilitation #MentalHealth #Anxiety # Poikilothermia https://twitter.com/NHausMD To contact the RehabCast team go to https://acrm.org/publications/archives-of-pm-r/rehabcast/ Contact Philip Frobos at https://www.instagram.com/philipfrobos/ Contact Dr Niehaus at https://twitter.com/NHausMD

When back pain leads to back surgeries and long term debilitating pain and anxiety leads to missing out on your authentic self, diving deeper into the why behind it all became an urgent exploration for Caitlin. In this episode, she shares about the complicated and diverse nature in which people encounter chronic pain, and elaborates on her experience with chronic pain and anxiety across her life.  TW: Eating disordersSources:Aroke, E. N., Joseph, P. V., Roy, A., Overstreet, D. S., Tollefsbol, T. O., Vance, D. E., & Goodin, B. R. (2019). Could epigenetics help explain racial disparities in chronic pain? Journal of Pain Research, Volume 12, 701–710. https://doi.org/10.2147/jpr.s191848Biopsychosocial Factors that Underlie Racial Disparities in Pain Outcomes, Comorbidities, Inequities, and Barriers to Treatment. Current Pain and Headache Reports, 27(1), 1–10. https://doi.org/10.1007/s11916-022-01098-8 Chronic Pain. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/4798-chronic-pain Mossey, J. (2011b). Defining Racial and Ethnic Disparities in Pain Management. Clinical Orthopaedics and Related Research, 469(7), 1859–1870. https://doi.org/10.1007/s11999-011-1770-9Nestel, S. (2012). Colour Coded Health Care: The Impact of Race and Racism on Canadians' Health. In The Wellesley Institute. https://www.wellesleyinstitute.com/wp-content/uploads/2012/02/Colour-Coded-Health-Care-Sheryl-Nestel.pdfNew Fact Sheets Show Growing Racial Disparities in Canada | OCASI. (n.d.). https://ocasi.org/new-fact-sheets-show-growing-racial-disparities-canadaOverstreet, D. S., Pester, B. D., Wilson, J. M., Flowers, K. M., Kline, N. K., & Meints, S. M. (2022). The Experience of BIPOC Living with Chronic Pain in the USA: Biopsychosocial Factors that Underlie Racial Disparities in Pain Outcomes, Comorbidities, Inequities, and Barriers to Treatment. Current Pain and Headache Reports, 27(1), 1–10. https://doi.org/10.1007/s11916-022-01098-8Socioeconomic status and occurrence of chronic pain: a meta-analysis. Rheumatology, 60(3), 1091–1105. https://doi.org/10.1093/rheumatology/keaa758 What are Anxiety Disorders? (n.d.). https://www.psychiatry.org/patients-families/anxiety-disorders/what-are-anxiety-disorders#:~:text=Anxiety%20is%20a%20normal%20reaction,involve%20excessive%20fear%20or%20anxiety.Remember that we never walk this journey alone. Helpful numbers if you or someone you love finds themself in need quickly:988- suicide and crisis hotline741 741 - crisis text hotline911- medical emergencies

Welcome to Group Therapy!! Licensed psychologists Dr. Jessica Rabon, Dr. Justin Puder, Dr. Kristen Casey and licensed therapist Kristen Gingrich LCSW, CADC, CCS are coming together to create a podcast to talk about topics chosen by you, the listeners, in a laid back, relatable way. Kinda like group therapy. From mental health to relationships, hot topics to current events, fun topics and everything in between, including cultural influences on mental health and therapy, our goal is for your voices to be heard and you to feel like you are part of the group. So settle in, take a seat, and Welcome to Group Therapy! Disclaimer: Welcome to Group Therapy Podcast is not a replacement for therapy, is not actual group therapy, nor will specific therapeutic advice be given on the show. Although we are all licensed therapists, we are not YOUR therapist. It is meant to be for educational and entertainment purposes only. Follow us on social media!Instagram: @welcometogrouptherapypod TikTok: @welcometogrouptherapypod Submit your podcast topic requests here! Dr. Justin Puder @amoderntherapist Dr. Kristen Casey @drkristencasey Dr. Jessica Rabon @jessicaleighphd Kristen Gingrich LCSW, CADC, CSS @notyouraveragethrpst Article: Racial and Ethnic Disparities in Mental Health and Mental Health Care During The COVID-19 Pandemic https://link.springer.com/article/10.1007/s40615-022-01284-9 (https://link.springer.com/article/10.1007/s40615-022-01284-9)

Dr. Dylan J. Jester (VA Palo Alto Medical Center in Palo Alto, California) joins AJP Audio to discuss the differential impact of selected social determinants of health on the mental health outcomes of older Black, White, and Latinx adults in the United States. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses how issues of substance use disorder draw together the rest of the July issue. Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Stitcher, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. How authors may submit their work. Follow the journals of APA Publishing on Twitter. E-mail us at ajp@psych.org  

On this month's episode of “The Table: Conversations on Youth Justice,” Husain talks to Josh Rovner from the Sentencing Project about diverting youth from the juvenile justice system. They talk about the merits of diversion practices, and Husain discusses MCYJ's efforts to promote diversion across the state. For more information: Diversion: A Hidden Key to Combating Racial and Ethnic Disparities in Juvenile Justice Opinion | Michigan needs a statewide approach to reform juvenile justice (Bridge) Michigan's Task Force On Juvenile Justice Reform Approves Comprehensive Blueprint For Transforming Juvenile Justice StatewideReach out to Husain: hhaidri@miyouthjustice.org Hosted on Acast. See acast.com/privacy for more information.

"There's no single discipline that's gonna be able to really understand how structures and systems have been created to produce racial inequality in this country... Interdisciplinary collaboration is key to this work, particularly if we are focused on identifying and dismantling systemic racism." In this episode, Dr. Keon Gilbert is in conversation with Dr. Brian Smedley, the Study Director at the Institute of Medicine for the landmark report entitled “Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care." Twenty years later, they reflect back on the paper as a beacon for HPP's “What is Antiracism in Health Promotion Practice?” series. Dr. Smedley calls for robust, comprehensive data collection, monitoring, and public reporting in order to monitor for access, quality of care, and outcomes of care. They also discuss the reallocation of healthcare resources and centering of community voices in the redesigning of these systems. Other recently published papers in HPP's What is Anti-Racism in Health Promotion Practice series:  "Dear Health Promotion Scholar: Letters of Life From, for, and About Black Women in Academia" by LaNita S. Wright, PhD, Juliet Iwelunmor, PhD, and Jeanetta D. Sims, PhD "PRESENCE//Gifted: On Poetry, Anti-Racism, and Epistemic Violence in Health Promotion" by Ryan Petteway.  Dr. Petteway is an HPP Associate Editor for our Poetry for the Public's Health section and also the recipient of HPP's 2021 Paper of the Year Award.  "Examining the White Supremacist Practices of Funding Organizations for Public Health Reearch and Practice: A Composite Narrative from Female, BIPOC Junior Researchers in Public Health" by Elizabeth Chen, Deshira Wallace, Cristina Leos, and Yesenia Merino.

Are there state variations in racial and ethnic disparities in the incidence of triple-negative breast cancer in the US? Find out about this and more in today's PVRoundup podcast.

When a person's heart stops beating, how quickly cardiopulmonary resuscitation (CPR) is administered can be the difference between life and death. Knowing CPR can save a person's life, but some groups are less likely to take the training.

Aleesha Jantzen, PharmD describes social determinants of health that impact management of cardiovascular disease states, recognizes racial/ethnic disparities in management of atrial fibrillation, myocardial infection, hypertension, and heart failure and identifies pharmacist interventions to minimize racial/ethnic disparities in cardiovascular disease state management. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter! You can also connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Navdep Kaur, M.P.H., joins Dr. Dixon and Dr. Berezin to discuss persistent racial and ethnic disparities in mental health treatment access and outcomes prior to and following the passage of the 2010 Affordable Care Act.  Ms. Kaur is a predoctoral fellow at the Columbia University Mailman School of Public Health in New York. Kaur interview [01:01] Connecting your work with your passion [03:09] Affordable Care Act and mental health [05:39] What did you look at to study this? [09:11] What are we talking about when we talk about distress? [10:06] How do you define treatment usage? [11:30] What are your hypotheses for why your findings on mental health treatment usage look the way they do? [13:11] Disaggregating data for disparate groups [14:40] Has the amount of treatment change overall differed between subgroups and the whole population? [17:42] How do you categorize the various levels of stigma and attitudes towards treatment? [19:16] Sources of market failure – lack of providers, insurance, access [21:21] What would a data set that could answer your questions look like? [22:22] What are you working on next? [24:34] Has your passion survived contact with sample sizes, measures, and the nitty gritty of data sets? [25:20] Transcript Subscribe to the podcast here. Check out Editor's Choice, a set of curated collections from the rich resource of articles published in the journal. Sign up to receive notification of new Editor's Choice collections. Browse other articles on our website. Be sure to let your colleagues know about the podcast, and please rate and review it wherever you listen to it. Listen to other podcasts produced by the American Psychiatric Association. Follow the journal on Twitter. E-mail us at psjournal@psych.org

This recording features audio versions of December 2022  Journal of Vascular and Interventional Radiology (JVIR) abstracts:Racial and Ethnic Disparities among Participants in Hepatocellular Carcinoma Clinical Studies Evaluating Transarterial Therapies ReadComparison of Bolus Versus Dual-Syringe Administration Systems on Glass Yttrium-90 Microsphere Deposition in an In Vitro Microvascular Hepatic Tumor Model ReadSalvage Cryoablation for Local Recurrences of Thyroid Cancer Inseparable from the Trachea and Neurovascular Structures ReadClinical Outcomes of Transarterial Embolization for Chronic Achilles Tendinopathy Refractory to Conservative Treatment: A Pilot Study ReadIntra-articular Injection of Bone Marrow Concentrate for Treatment of Patellofemoral Osteoarthritis: Preliminary Results Utilizing an Ultrasound-Guided Marrow Harvesting Technique ReadPercutaneous Radiofrequency Sympatholysis in the Treatment of Primary Palmar Hyperhidrosis: A Retrospective Case-Controlled Study of Rib-Based Anatomical Targeting ReadUnplanned 30-Day Readmissions after Management of Submassive and Massive Acute Pulmonary Embolism: Catheter-Directed versus Systemic Thrombolysis Read JVIR and SIR thank all those who helped record this episode:Host and audio editor:Daniel Kim, Edward Via College of Osteopathic Medicine, VirginiaAbstract readers:Jacob Knittel, Creighton University School of Medicine Phoenix Regional Campus, ArizonaAleksandr Zyskin, MS, Eastern Virginia Medical SchoolAnna Hu, George Washington University School of Medicine, District of ColumbiaShunn Theingi, Lewis Katz School of Medicine, PennsylvaniaEric Juang, MS, Creighton University School of Medicine Phoenix Regional Campus, ArizonaAnne-Marie Nwajei, MS, The Chicago Medical School at Rosalind Franklin University of Medicine and ScienceAndrew Han, MEd, Liberty University College of Osteopathic Medicine, Virginia ©  Society of Interventional RadiologySupport the show

In this episode, AANP Fellows Nancy Berman and Dr. Kahlil Demonbreun discuss ways to initiate effective and respectful conversations with women of different ethnic, cultural and racial backgrounds who may experience symptoms of menopause and perimenopause differently. They review current guidelines and address common misconceptions regarding the treatment of systemic and genitourinary symptoms. To earn continuing education (CE) credit for this episode, you will need the participation code provided at the end of the podcast. To claim your CE and pharmacology credit, log in and register for the activity within the AANP CE Center, then enter the participation code and complete the posttest and evaluation.

Hi FreshEd Listeners. We're on holiday for the month of August. We'll be back in September with new episodes, including the next round of Flux. I've already listened to a few rough cuts and they're going to be great. While we're away, please send us your recommendations for future guests as well as consider donating to FreshEd to keep independent media alive. FreshEd is nothing without you. Thanks for all your support and I'll be back in September! freshedpodcast.com/contact-2/ -- Today the journalist, author, and academic, Gary Younge, joins me to talk about race, identity, and education. Our conversation starts with his reflections on the UK Government's Commission on Race and Ethnic Disparities, which published its report in March. We then touch on a range of issues from across his career. Gary Younge is a professor of sociology at the University of Manchester. He worked for the Guardian newspaper for two decades and has written five books. His book Who are We – and should it matter in the 21st century? was recently re-released with an updated introduction. In May, he released his latest BBC radio documentary called Thinking in Colour. freshedpodcast.com/younge/ -- Get in touch! Twitter: @FreshEdpodcast Facebook: FreshEd Email: info@freshedpodcast.com Support FreshEd: www.freshedpodcast.com/donate

Yesterday, Dr. Meera Shah of Nova IVF was a guest on The Egg Whisperer Show podcast and we talked about ethnic differences that exist in women's reproductive health, and how they impact IVF outcomes.⁠ ⁠So many of you wrote in asking about our interview that I wanted to bring Dr. Shah back, and in this episode we answered your fertility questions, live.  Read the full show notes on Dr. Aimee's website Find Dr. Meera Shah at Nova IVF here Would you like to learn about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, August 22, 2022 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Subscribe to my YouTube channel for more fertility tips! Join Egg Whisperer School Checkout the podcast Subscribe to the newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

Dr. Meera Shah from Nova IVF in Mountain View, California joins me on the podcast today to talk about differences and disparities in reproductive health and IVF outcomes among people of different ethnicities. Dr. Shah has done a great deal of research on this topic and she will be sharing her work. More specifically, we'll be talking about: the timing of a girl's first period, fibroids, menopause, miscarriage, and IVF outcomes based on ethnicity and how this information could help you.⠀ Read the full show notes on Dr. Aimee's website Find Dr. Meera Shah at Nova IVF here Would you like to learn about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, August 22, 2022 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Subscribe to my YouTube channel for more fertility tips! Join Egg Whisperer School Checkout the podcast Subscribe to the newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

Dr. Rae Bacharach discusses the Neurology article, "Racial and Ethnic Disparities in Multiple Sclerosis Prevalence". Show references: Racial and Ethnic Disparities in Multiple Sclerosis Prevalence This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Drs. B.J. Hicks and Andy Southerland talk with Dr. Scott Mendelson about racial and ethnic disparities in the rates of declination of thrombolysis in patients with acute ischemic stroke. Read the full article in Neurology.

Dr. Scott Mendelson discusses racial and ethnic disparities in the rates of declination of thrombolysis in patients with acute ischemic stroke.  Show references: https://n.neurology.org/content/early/2022/02/28/WNL.0000000000200138

John McWhorter is back once more for an episode of The Glenn Show, so let’s get into it. I begin by reporting on my current “European Tour.” Last week I spoke at the London School of Economics, and I’m currently headed from Toulouse, France to Marseille to deliver the keynote address at the International Conference on Public Economic Theory. It’s been quite an enlightening experience so far, as I’ve gotten a look at how young black European economists are thinking about inequities within and without their profession. John and I discuss a recent report from the Commission on Race and Ethnic Disparities, which offers a picture of racial disparities in the UK that differs greatly from that of the US. But as John notes, the impression that people abroad have of our problems is often distorted. One of our real problems is our tendency to filter all thinking about race and ethnicity through “blacks and whites.” The US is a much more diverse place that that, and John and I ask how long the concerns of African Americans will determine the national agenda for all “people of color.” Next, John asks a big question: What is the real cause of racial disparities in the commission of violent crime? We know that black perpetrators are responsible for a disproportionate amount of violent crime, but we need to understand why. I gently chide John for missing the recent Old Parkland Conference, but he’s got a good excuse: He was busy recording a series of lectures about the history of the alphabet for the Great Courses! I am utterly fascinated by this project, and I convince John to give us a preview. And finally, I offer a critique of John’s recent column, which addresses school shootings. This one is buoyant and weighty in equal measure. As always, I want to hear your thoughts. Let me know in the comments!This post is free and available to the public. To receive early access to TGS episodes, an ad-free podcast feed, Q&As, and other exclusive content and benefits, click below.0:00 Race and economics in the UK 14:26 How long will the concerns of native-born black Americans drive the race conversation? 23:15 The shaky “people of color” coalition 27:51 Trying to account for racial disparities in the commission of violent crime 39:44 Reclaiming moral agency from white people 42:37 The Old Parkland conference 44:37 John’s forthcoming lectures on the alphabet 51:47 Glenn’s critique of John’s school shooting columnLinks and ReadingsThe “Sewell Report” from the UK’s Commission on Race and Ethnic DisparitiesAmy Chua and Jed Rubenfeld’s book, The Triple Package: How Three Unlikely Traits Explain the Rise and Fall of Cultural Groups in AmericaEzra Klein’s interview with Reihan SalamGlenn and John’s conversation with Randall KennedyIan Rowe’s book, Agency: The Four Point Plan (F.R.E.E.) for ALL Children to Overcome the Victimhood Narrative and Discover Their Pathway to PowerJohn’s recent NYT column, “Gun Violence Is Like What Segregation Was. An Unaddressed Moral Stain.” This is a public episode. If you’d like to discuss this with other subscribers or get access to bonus episodes, visit glennloury.substack.com/subscribe

For some, the journey to their MS diagnosis is relatively quick and straightforward. For others, it can be lengthy and convoluted, sometimes  taking years. Joining me to talk about some of the twists and turns that can pop up on the road to being diagnosed with MS is Dr. Michael Robers, a neurologist in the Multiple Sclerosis Program and an assistant professor in the Department of Neurology at Barrow Neurological Institute. We're also talking about a study that measured MS prevalence among Black, White, Hispanic, and Asian people. We'll share results of a survey that looked at cannabis use among Canadians living with MS. We're also sharing results of a survey that looked at where Americans living with MS get their information about cannabis. If you're an MS caregiver, healthcare professional, or researcher, we'll give you the details about an important survey that you can participate in. And we're even taking a moment for a special thank you! We have a lot to talk about! Are you ready for RealTalk MS??! A quick look at the numbers and a heartfelt thank you!   :22 A date that each person remembers 2:59 Study looks at MS prevalence among different racial and ethnic groups  4:36 Survey results show cannabis use among Canadians with MS    7:41 Where do you get your information?  10:07 Survey results show where Americans with MS get their information and guidance about cannabis  11:20 An important survey for MS caregivers, healthcare professionals, and researchers  14:37 Dr. Michael Robers discusses the journey to an MS diagnosis  17:03 Share this episode  31:20 Download the RealTalk MS app for your iOS or Android device   31:41 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/245 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com National MS Society COVID-19 Vaccine Guidance for People Living with MS https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance STUDY: Racial and Ethnic Disparities in Multiple Sclerosis Prevalence https://n.neurology.org/content/98/18/e1818 SURVEY: Medical Cannabis Used in Canadians with Multiple Sclerosis https://www.msard-journal.com/article/S2211-0348(22)00153-5/fulltext SURVEY: Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living with Multiple Sclerosis https://cp.neurology.org/content/12/2/102 iConquer MS Survey for MS Caregivers https://survey.alchemer.com/s3/6823942/Caregiver-Survey-MS-Caregivers iConquer MS Survey for Researchers and Healthcare Providers https://survey.alchemer.com/s3/6823815/Caregiver-research-survey-HCPs-and-researchers Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 245 Guests: Dr. Michael Robers Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS Privacy Policy